Pearlify UI

Pearlify Data Viewer

read-only

홈 · 표

재무제표 주요계정

보고서별 핵심 계정(매출·이익·자산 등). 계정명은 공시 원문 그대로, 지표는 규칙으로 매핑합니다.

기술 정보 숨기기
ID수집원원본 키발생값 ↑시간 정밀도시간 의미관측 가능 시각적재일시원본 레코드파서 버전원시 식별자법인DART 코드회사명사업연도기간연결구분재무제표계정명표준 지표금액통화기준일접수번호
cmrxew1pn01wk0zgw81f97cjzdart-financials00877059:2025:11011:CFS:BS:자본총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYCFSBS자본총계total_equity7.4조원KRW2025-12-3120260515001658
cmrxew1pt01wl0zgwhw5ain98dart-financials00877059:2025:11011:CFS:IS:매출액2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYCFSIS매출액revenue4.5조원KRW2025-12-3120260515001658
cmrxew1pz01wm0zgw7fafu4eadart-financials00877059:2025:11011:CFS:IS:영업이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYCFSIS영업이익operating_income2조원KRW2025-12-3120260515001658
cmrxew1q601wn0zgw341dd3wzdart-financials00877059:2025:11011:CFS:IS:법인세차감전 순이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYCFSIS법인세차감전 순이익pretax_income2.1조원KRW2025-12-3120260515001658
cmrxew1qc01wo0zgw4czk7oludart-financials00877059:2025:11011:CFS:IS:당기순이익(손실)2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYCFSIS당기순이익(손실)net_income1.7조원KRW2025-12-3120260515001658
cmrxew1qi01wp0zgwidupkq8ldart-financials00877059:2025:11011:CFS:IS:총포괄손익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYCFSIS총포괄손익comprehensive_income1.7조원KRW2025-12-3120260515001658
cmrxew1qp01wq0zgw5fv1wpp2dart-financials00877059:2025:11011:OFS:BS:유동자산2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS유동자산current_assets4.3조원KRW2025-12-3120260515001658
cmrxew1qv01wr0zgwfhromoo1dart-financials00877059:2025:11011:OFS:BS:비유동자산2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS비유동자산non_current_assets6.6조원KRW2025-12-3120260515001658
cmrxew1r201ws0zgw7e5gu55ndart-financials00877059:2025:11011:OFS:BS:자산총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS자산총계total_assets11조원KRW2025-12-3120260515001658
cmrxew1r801wt0zgwdqdf8cghdart-financials00877059:2025:11011:OFS:BS:유동부채2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS유동부채current_liabilities2.5조원KRW2025-12-3120260515001658
cmrxew1rf01wu0zgwglq8imdjdart-financials00877059:2025:11011:OFS:BS:비유동부채2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS비유동부채non_current_liabilities1조원KRW2025-12-3120260515001658
cmrxew1rl01wv0zgwurvck0bodart-financials00877059:2025:11011:OFS:BS:부채총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS부채총계total_liabilities3.6조원KRW2025-12-3120260515001658
cmrxew1rs01ww0zgwdhh32rxwdart-financials00877059:2025:11011:OFS:BS:자본금2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS자본금capital_stock1157.2억원KRW2025-12-3120260515001658
cmrxew1ry01wx0zgwcwudumkndart-financials00877059:2025:11011:OFS:BS:이익잉여금2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS이익잉여금retained_earnings5조원KRW2025-12-3120260515001658
cmrxew1s501wy0zgwqcuekyqjdart-financials00877059:2025:11011:OFS:BS:자본총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSBS자본총계total_equity7.4조원KRW2025-12-3120260515001658
cmrxew1sb01wz0zgwopr79sxfdart-financials00877059:2025:11011:OFS:IS:매출액2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSIS매출액revenue4.5조원KRW2025-12-3120260515001658
cmrxew1si01x00zgwrnzyqjondart-financials00877059:2025:11011:OFS:IS:영업이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSIS영업이익operating_income2조원KRW2025-12-3120260515001658
cmrxew1so01x10zgw54ja1lildart-financials00877059:2025:11011:OFS:IS:법인세차감전 순이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSIS법인세차감전 순이익pretax_income2조원KRW2025-12-3120260515001658
cmrxew1st01x20zgwyuhi5qxsdart-financials00877059:2025:11011:OFS:IS:당기순이익(손실)2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSIS당기순이익(손실)net_income1.5조원KRW2025-12-3120260515001658
cmrxew1sz01x30zgwu7yikmqsdart-financials00877059:2025:11011:OFS:IS:총포괄손익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1o801wb0zgwwa4c970l1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025FYOFSIS총포괄손익comprehensive_income1.5조원KRW2025-12-3120260515001658
cmrxew1tb01x50zgw91muyzvrdart-financials00877059:2026:11013:CFS:BS:유동자산2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS유동자산current_assets4.6조원KRW2026-03-3120260515002129
cmrxew1th01x60zgw97nxkwpwdart-financials00877059:2026:11013:CFS:BS:비유동자산2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS비유동자산non_current_assets7.3조원KRW2026-03-3120260515002129
cmrxew1tn01x70zgw0cpk0ej2dart-financials00877059:2026:11013:CFS:BS:자산총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS자산총계total_assets11.9조원KRW2026-03-3120260515002129
cmrxew1tt01x80zgwcessbqjydart-financials00877059:2026:11013:CFS:BS:유동부채2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS유동부채current_liabilities2.7조원KRW2026-03-3120260515002129
cmrxew1tz01x90zgwqqqcadcndart-financials00877059:2026:11013:CFS:BS:비유동부채2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS비유동부채non_current_liabilities1.3조원KRW2026-03-3120260515002129
cmrxew1u501xa0zgwuxy2hckpdart-financials00877059:2026:11013:CFS:BS:부채총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS부채총계total_liabilities4조원KRW2026-03-3120260515002129
cmrxew1ub01xb0zgwxpmi3919dart-financials00877059:2026:11013:CFS:BS:자본금2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS자본금capital_stock1157.2억원KRW2026-03-3120260515002129
cmrxew1uh01xc0zgw021ixjjmdart-financials00877059:2026:11013:CFS:BS:이익잉여금2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS이익잉여금retained_earnings7.3조원KRW2026-03-3120260515002129
cmrxew1uo01xd0zgwaelgt477dart-financials00877059:2026:11013:CFS:BS:자본총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSBS자본총계total_equity7.9조원KRW2026-03-3120260515002129
cmrxew1uu01xe0zgw812kj081dart-financials00877059:2026:11013:CFS:IS:매출액2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSIS매출액revenue1.2조원KRW2026-03-3120260515002129
cmrxew1v101xf0zgwurmuekh9dart-financials00877059:2026:11013:CFS:IS:영업이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSIS영업이익operating_income5807.5억원KRW2026-03-3120260515002129
cmrxew1v701xg0zgwxl2palimdart-financials00877059:2026:11013:CFS:IS:법인세차감전 순이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSIS법인세차감전 순이익pretax_income6405.9억원KRW2026-03-3120260515002129
cmrxew1ve01xh0zgwri4hnp7rdart-financials00877059:2026:11013:CFS:IS:당기순이익(손실)2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSIS당기순이익(손실)net_income4692.4억원KRW2026-03-3120260515002129
cmrxew1vk01xi0zgwin640nledart-financials00877059:2026:11013:CFS:IS:총포괄손익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1CFSIS총포괄손익comprehensive_income4717.2억원KRW2026-03-3120260515002129
cmrxew1vr01xj0zgwmkp6lbmhdart-financials00877059:2026:11013:OFS:BS:유동자산2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS유동자산current_assets4.5조원KRW2026-03-3120260515002129
cmrxew1vx01xk0zgwd7xxvlkddart-financials00877059:2026:11013:OFS:BS:비유동자산2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS비유동자산non_current_assets7.1조원KRW2026-03-3120260515002129
cmrxew1w401xl0zgww6ruu9y5dart-financials00877059:2026:11013:OFS:BS:자산총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS자산총계total_assets11.6조원KRW2026-03-3120260515002129
cmrxew1wa01xm0zgwylxcbjeddart-financials00877059:2026:11013:OFS:BS:유동부채2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS유동부채current_liabilities2.6조원KRW2026-03-3120260515002129
cmrxew1wh01xn0zgwxl6s2r5gdart-financials00877059:2026:11013:OFS:BS:비유동부채2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS비유동부채non_current_liabilities1조원KRW2026-03-3120260515002129
cmrxew1wm01xo0zgwyod2ruevdart-financials00877059:2026:11013:OFS:BS:부채총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS부채총계total_liabilities3.7조원KRW2026-03-3120260515002129
cmrxew1ws01xp0zgwah9uytfndart-financials00877059:2026:11013:OFS:BS:자본금2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS자본금capital_stock1157.2억원KRW2026-03-3120260515002129
cmrxew1wy01xq0zgwk8h3k7ysdart-financials00877059:2026:11013:OFS:BS:이익잉여금2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS이익잉여금retained_earnings5.5조원KRW2026-03-3120260515002129
cmrxew1x401xr0zgwf8yu3tjtdart-financials00877059:2026:11013:OFS:BS:자본총계2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSBS자본총계total_equity7.8조원KRW2026-03-3120260515002129
cmrxew1xa01xs0zgwnptnw5jfdart-financials00877059:2026:11013:OFS:IS:매출액2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSIS매출액revenue1.2조원KRW2026-03-3120260515002129
cmrxew1xg01xt0zgwzfymq2w4dart-financials00877059:2026:11013:OFS:IS:영업이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSIS영업이익operating_income5805.7억원KRW2026-03-3120260515002129
cmrxew1xm01xu0zgwyf5yuyigdart-financials00877059:2026:11013:OFS:IS:법인세차감전 순이익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSIS법인세차감전 순이익pretax_income6454.3억원KRW2026-03-3120260515002129
cmrxew1xs01xv0zgwqycrs5hedart-financials00877059:2026:11013:OFS:IS:당기순이익(손실)2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSIS당기순이익(손실)net_income4741.4억원KRW2026-03-3120260515002129
cmrxew1xy01xw0zgw9kmo8agrdart-financials00877059:2026:11013:OFS:IS:총포괄손익2026-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:07cmrxew1t701x40zgwb08h6f251
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,026Q1OFSIS총포괄손익comprehensive_income4732.5억원KRW2026-03-3120260515002129
cmrxevy6j01c80zgwt9wh4uwbdart-financials00413046:2026:11013:OFS:IS:총포괄손익2026-05-15dayevent2026-07-23 20:12:022026-07-23 20:12:02cmrxevy3f01bg0zgwsxoh4c0x1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,026Q1OFSIS총포괄손익comprehensive_income3660.7억원KRW2026-03-3120260515002932
cmrxevy6e01c70zgw9y0j9zeydart-financials00413046:2026:11013:OFS:IS:당기순이익(손실)2026-05-15dayevent2026-07-23 20:12:022026-07-23 20:12:02cmrxevy3f01bg0zgwsxoh4c0x1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,026Q1OFSIS당기순이익(손실)net_income3650억원KRW2026-03-3120260515002932
4,008건 중 2,651–2,700← 이전54 / 81 쪽다음 →

fundamental_facts · 컬럼 24개 · occurredAt asc 정렬